| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.344 | 51.365 | 48.246 | 35.072 | 5.545 | 248 | 0 | 2.377 | 7.811 | 8.538 |
| Total Income - EUR | 36.344 | 54.526 | 48.246 | 37.651 | 6.113 | 248 | 0 | 2.377 | 7.811 | 8.538 |
| Total Expenses - EUR | 28.732 | 23.589 | 31.210 | 17.330 | 6.388 | 7.042 | 5.279 | 5.813 | 10.645 | 9.906 |
| Gross Profit/Loss - EUR | 7.613 | 30.937 | 17.036 | 20.321 | -275 | -6.794 | -5.279 | -3.436 | -2.834 | -1.368 |
| Net Profit/Loss - EUR | 6.529 | 30.401 | 16.555 | 19.617 | -338 | -6.796 | -5.279 | -3.507 | -2.834 | -1.624 |
| Employees | 7 | 0 | 7 | 6 | 4 | 4 | 4 | 4 | 4 | 1 |
Check the financial reports for the company - Doru Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 838 | 829 | 2.053 | 1.642 | 1.243 | 603 | 251 | 0 | 3.789 | 3.768 |
| Current Assets | 32.431 | 47.861 | 33.787 | 26.824 | 24.982 | 16.730 | 12.051 | 8.501 | 2.559 | 419 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 28.375 | 37.070 | 28.257 | 21.230 | 20.310 | 15.669 | 11.563 | 7.417 | 2.254 | 213 |
| Cash | 4.056 | 10.791 | 5.530 | 5.594 | 4.673 | 1.061 | 488 | 1.084 | 305 | 206 |
| Shareholders Funds | 30.433 | 30.456 | 16.610 | 19.671 | 18.908 | 11.753 | 6.214 | 2.726 | -117 | -1.741 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.835 | 18.234 | 19.231 | 8.795 | 7.317 | 5.581 | 6.088 | 5.775 | 6.465 | 5.928 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Doru Med Srl